¹û¶³Ö±²¥ÊÓƵ

Vaccinating women in pregnancy can protect women and their infants from infectious diseases. This intervention is increasingly recognised as a safe and effective way to reduce infant morbidity and mortality.  

​In this seminar Professor Beate Kampmann (Charite Berlin/LSHTM) will provide the biological and historical background for maternal vaccination, setting the scene for presentations on the development of Group B Streptococcus (GBS) and Respiratory Syncytial Virus (RSV) vaccines. Dr Robert Mboizi (MU-JHU Uganda) will talk about GBS vaccine trials taking place in Uganda and Dr Simon Procter (LSHTM) will present an analysis on the global value of GBS maternal vaccines. Professor Paul Heath (St George’s, University of London) will provide an update on the RSV vaccine pipeline and Dr David Hodgson (LSHTM) will discuss mathematical modelling work on evaluating the cost-effectiveness of interventions aimed at preventing RSV.   

​There will be a drinks reception after the event in South Courtyard.  

Speakers

​​Professor Beate Kampmann, Charite Berlin and LSHTM 

​​Beate Kampmann is Professor of Global Health and the scientific director of the newly established Charite Centre for Global Health and the Institut fur Internationale Gesundheit, Charite Virchow Campus, Charite Universitatsmedizin, Berlin.  

After more than 30 years abroad, she recently relocated to Berlin from a Chair in Paediatric Infection & Immunity at The London School of Hygiene and Tropical Medicine (LSHTM), where she directed the Vaccine Centre at LSHTM. Over the last 12 years, she has divided her working time between London and The Gambia, West Africa, where she led the vaccine research at the MRC Unit-The Gambia and still continues to manage her project and PhD student supervision.   

​Beate trained as a clinician-scientist in paediatric infectious diseases in Germany, France, USA, South Africa and the UK and holds an MD from the University of Cologne and a PhD from Imperial College, UK. She is a Fellow of the Academy of Medical Sciences, the Royal College of Paediatrics and Child Health in the UK and the West African College of Physicians and an MRC Senior Researcher.   

​​Her translational research portfolio focuses on innate and acquired immune responses to infection and vaccination, including in pregnant women and infants and the conduct of clinical trials of novel vaccines and adjuvants. She is the director of - the IMmunising PRegnant women and INfants network, a UKRI-GCRF-funded multi-disciplinary and global network of scientists, clinicians and public health representatives with a special interest in vaccines for pregnant women and newborns.   

​​Dr Robert Mboizi, MHU-JU Uganda 

Robert Mboizi is an Investigator and Program Manager at MUJHU Care Ltd/MUJHU Research Collaboration and is a medical researcher with over 15 years of clinical research experience across three African countries (Malawi, The Gambia and Uganda). He is passionate about Maternal and infant vaccines research to reduce morbidity and mortality from vaccine preventable or potentially vaccine preventable diseases. Robert obtained his medical degree at Makerere University medical school in Uganda and second level master in vaccinology and pharmaceutical clinical development from the university of Siena in Italy.

​​Dr Robert Mboizi, MHU-JU Uganda 

Robert Mboizi is an Investigator and Program Manager at MUJHU Care Ltd/MUJHU Research Collaboration and is a medical researcher with over 15 years of clinical research experience across three African countries (Malawi, The Gambia and Uganda). He is passionate about Maternal and infant vaccines research to reduce morbidity and mortality from vaccine preventable or potentially vaccine preventable diseases. Robert obtained his medical degree at Makerere University medical school in Uganda and second level master in vaccinology and pharmaceutical clinical development from the university of Siena in Italy.

Dr Simon Procter, LSHTM 

 

Professor Paul Heath, St George’s University Hospital 

Paul Heath is a Professor and Honorary Consultant in Paediatric Infectious Diseases at St George's University Hospitals NHS Foundation Trust and St George’s, University of London, where he is the Director of the Vaccine Institute. His training in paediatrics and infectious diseases was at the Royal Children’s Hospital, Melbourne, Australia; the John Radcliffe Hospital, Oxford; and St George’s Hospital, London. His research interests are in the epidemiology of vaccine preventable diseases, in clinical vaccine trials, particularly in at-risk groups and in perinatal infections. He coordinates a  and the UK Paediatric Vaccine Group (UKPVG), and other work includes national UK surveillance on neonatal infections, maternal immunisation trials, vaccine studies in preterm infants and COVID-19 vaccine trials (including in pregnant women). He sits on national UK committees concerned with meningitis and Group B streptococcus prevention and is a member of the JCVI. He is Chair of the Research Committee of the European Society of Paediatric Infectious Diseases, Section Editor of the Pediatric Infectious Diseases Journal (maternal & neonatal), NIHR Speciality Lead for Children’s research for South London CRN and a member of the WHO GBS Working Group.

​Dr David Hodgson, LSHTM